Extent of disease: Patients with 10% or less vitiligo and particularly facial or limited lesions tend to benefit most from ...
Vitiligo, an autoimmune skin disease known to many as the "Michael Jackson Disease", affects about 1% of the population and chances are you know someone who has it! In Episode 23, Skincast hosts Luke ...
Combining ultraviolet (UV) phototherapy with the Janus kinase (JAK) inhibitor baricitinib (Olumiant) helped patients with extensive vitiligo see significantly more repigmentation compared with a ...
BOSTON — Patients with vitiligo treated with a topical formulation of the Janus kinase (JAK) inhibitor ruxolitinib had significant repigmentation after 1 year on the therapy, reported investigators ...
Key opinion leaders discuss how diagnosing vitiligo can lead to myriad treatment options. Jeffrey D. Dunn, PharmD, MBA: Is diagnosing vitiligo pretty straightforward? Are there examples where it isn’t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results